Dexcom Inc [DXCM] stock prices are up 0.84% to $67.42 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The DXCM shares have gain 2.54% over the last week, with a monthly amount glided 8.37%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on December 02, 2025, when Morgan Stanley upgraded its rating to an Overweight but kept the price target unchanged to $75 for it. Previously, Evercore ISI started tracking the stock with In-line rating on November 25, 2025, and set its price target to $68. Oppenheimer downgraded its rating to a Perform. Argus initiated its recommendation with a Buy and recommended $100 as its price target on August 21, 2025. Truist started tracking with a Buy rating for this stock on June 16, 2025, and assigned it a price target of $102. In a note dated May 30, 2025, Goldman initiated a Buy rating and provided a target price of $104 on this stock.
The stock price of Dexcom Inc [DXCM] has been fluctuating between $54.11 and $93.25 over the past year. Currently, Wall Street analysts expect the stock to reach $85.18 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $67.42 at the most recent close of the market. An investor can expect a potential return of 26.34% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
The Dexcom Inc [NASDAQ:DXCM] reported sales of 4.52B for trailing twelve months, representing a surge of 21.64%. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.3 and Total Capital is 0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 66.94 points at the first support level, and at 66.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 67.70, and for the 2nd resistance point, it is at 67.99.
Ratios To Look Out For
It’s worth pointing out that Dexcom Inc [NASDAQ:DXCM]’s Current Ratio is 1.56. On the other hand, the Quick Ratio is 1.38, and the Cash Ratio is 0.55. Considering the valuation of this stock, the price to sales ratio is 5.82, the price to book ratio is 9.65 and price to earnings (TTM) ratio is 37.52.
Transactions by insiders
Recent insider trading involved Collins Richard Alexander, Director, that happened on Nov 14 ’25 when 2906.0 shares were sold. Director, Collins Richard Alexander completed a deal on Nov 14 ’25 to buy 2906.0 shares. Meanwhile, Director Heller Bridgette P sold 1012.0 shares on Nov 12 ’25.
